ELVN

Enliven Therapeutics, Inc.

NASDAQ NMS - GLOBAL MARKET· Pharmaceuticals· US· IPO 2020-03-12

$44.83

+0.20 (+0.45%)

last quote

Want the full multi-source brief on ELVN?

The agent pulls regulatory filings, news flow, prediction-market pricing, and macro context — then synthesizes what's not yet in the price.

open in agent

Today

Open

$44.83

High

$45.90

Low

$44.63

Previous close

$44.63

Fundamentals

Market cap

$3.30B

P/E (TTM)

—

P/S (TTM)

—

P/B

1.99x

Gross margin

—

Operating margin

—

Net margin

—

Rev growth (YoY)

—

EPS growth (YoY)

—

ROE

-18.55%

52W high

$62.32

52W low

$14.79

Beta

0.68x

Industry peers

by market cap

AMRX-1.13%LQDA+0.84%AMLX+4.14%OGN+0.22%TARS-0.93%MBX+1.10%PBH-0.38%CURA.TO

Upcoming earnings

next 30 days

2026-11-18in 13 days

Q3 2026EPS est $-0.46

Recent SEC filings

CIK 1672619filing-language history →

42026-11-03reports 2026-10-30

11 KB

SCHEDULE 13G/A2026-10-27

11 KB

42026-10-21reports 2026-10-19

9 KB

42026-10-21reports 2026-10-19

10 KB

1442026-10-19

6 KB

42026-10-16reports 2026-10-14

6 KB

SEC EDGAR Yahoo Finance TradingView Company website

This is the free preview

The agent layer adds regulatory-language drift detection, cross-venue prediction-market signals, macro overlays, programmable alert rules, overnight briefs, and a grounding verifier on every claim. 7-day Pro trial, no card required.

Start the trial